The effect of support by telephone on compliance with medication by osteoporosis patients using bisphosphonates objectivied by systematic control of serum bonemarkers

Completed

• Conditions: osteoporosis; 10013296; 10005959

• Registration Number: NL-OMON39186
• Lead Sponsor: Reinier de Graaf Groep

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 29 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 160

Inclusion Criteria

There are two parts in the study: RCT and observational study.
For the RCT (group 1 and 2)
Female patients with osteoporosis to whom an oral bisfosfonate will be prescribed
Age 50-85 years
Legally capable
After agreement they sign the informed consent form. ;For the observational study (reference group 3):
Female patients with osteoporosis to whom an intravenous bisfosfonate will be prescribed for medical reasons
Age 50-85 years
Legally capable
After agreement they sign the informed consent form. ;For the observational study (reference group 4):
Female patients with osteopenia to whom no medication will be prescribed
Age 50-85 years
Legally capable
After agreement they sign the informed consent form.

Exclusion Criteria

RCT:
Male patients
Age younger than 50 and older than 85 years
Legally incapable;Observational:
Age younger than 50 and older than 85 years
Legally incapable
No signed informed conscent form

Study & Design

• Study Type: Interventional
• Study Design: Not specified